743
Views
9
CrossRef citations to date
0
Altmetric
Neurotherapeutics

Cardiometabolic comorbidities and life expectancy in people on medication for schizophrenia in Australia

&
Pages 613-618 | Received 10 Oct 2017, Accepted 19 Dec 2017, Published online: 08 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Veronica Karlsson & Louise Danielsson. (2022) Motivators for patients with schizophrenia spectrum disorders to start and maintain exercising: a qualitative interview study. European Journal of Physiotherapy 24:1, pages 30-38.
Read now
Robert Stanton, Simon Rosenbaum, Amanda Rebar & Brenda Happell. (2019) Prevalence of Chronic Health Conditions in Australian Adults with Depression and/or Anxiety. Issues in Mental Health Nursing 40:10, pages 902-907.
Read now

Articles from other publishers (7)

Joe Kwun Nam Chan, Christoph U. Correll, Corine Sau Man Wong, Ryan Sai Ting Chu, Vivian Shi Cheng Fung, Gabbie Hou Sem Wong, Janet Hiu Ching Lei & Wing Chung Chang. (2023) Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis. eClinicalMedicine 65, pages 102294.
Crossref
Greg Spann, Lewis Austin & Edward King. (2022) Pharmacists in clozapine clinics improving physical health monitoring. Mental Health Clinician 12:3, pages 193-198.
Crossref
David J Castle, Malcolm Hopwood, Sanil Rege & David B George. (2021) Reducing metabolic syndrome in Australian patients: Metabolic Management During Antipsychotic Prescribing (MMAP) programme. Australasian Psychiatry 30:1, pages 84-89.
Crossref
Sallie-Anne Pearson, Nicole Pratt, Juliana de Oliveira Costa, Helga Zoega, Tracey-Lea Laba, Christopher Etherton-Beer, Frank M. Sanfilippo, Alice Morgan, Lisa Kalisch Ellett, Claudia Bruno, Erin Kelty, Maarten IJzerman, David B. Preen, Claire M. Vajdic & David Henry. (2021) Generating Real-World Evidence on the Quality Use, Benefits and Safety of Medicines in Australia: History, Challenges and a Roadmap for the Future. International Journal of Environmental Research and Public Health 18:24, pages 13345.
Crossref
Tomasz Pawełczyk, Marta Grancow-Grabka, Natalia Żurner & Agnieszka Pawełczyk. (2021) Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study. Schizophrenia Research 230, pages 61-68.
Crossref
David J Castle. (2019) The complexities of the borderline patient: how much more complex when considering physical health?. Australasian Psychiatry 27:6, pages 552-555.
Crossref
Jun Ren, James R. Sowers & Yingmei Zhang. (2018) Metabolic Stress, Autophagy, and Cardiovascular Aging: from Pathophysiology to Therapeutics. Trends in Endocrinology & Metabolism 29:10, pages 699-711.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.